| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |